If you have pain, instead of NSAIDs, use Tylenol
[12] Metformin: Anchor in the GLP-1 RA Care Continuum Journey The mechanistic, real-world, clinical trials and pharmacovigilance evidence landscape suggests metformin as the potential anchor pharmacological agent across the entire GLP-1 RA care continuum, during therapy and beyond.Table 1 summarises the key potential outcome benefits at each phase
Calcium and vitamin D status should be optimized before and throughout GLP-1 therapy
FDA Approves Oral Semaglutide as the First GLP-1 Pill for Weight Loss The FDAs recent approval of oral semaglutide marks a revolutionary milestone in obesity medicine, introducing the first daily pill to deliver the powerful weight loss results previously restricted to injectable therapies
and are used with permission
Many patients find that dose increases should be delayed by one week if nausea persists, allowing a smoother transition and more predictable weight-loss outcomes